CAN
WST icon

Cetera Advisor Networks’s West Pharmaceutical WST Stock Holding History

Cetera Advisor Networks’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5.81M Buy
14,673
+495
+3% +$183K 0.03% 566
2023
Q4 		$4.99M Buy
14,178
+529
+4% +$187K 0.03% 576
2023
Q3 		$5.12M Sell
13,649
-282
-2% -$109K 0.03% 511
2023
Q2 		$5.33M Sell
13,931
-1,473
-10% -$526K 0.04% 460
2023
Q1 		$5.34M Buy
15,404
+442
+3% +$129K 0.04% 445
2022
Q4 		$3.52M Buy
14,962
+13,832
+1,224% +$3.28M 0.03% 581
2022
Q3 		$278K Buy
+1,130
New +$344K ﹤0.01% 1653
2022
Q1 		– Sell
-491
Closed -$230K – 2192
2021
Q4 		$230K Sell
491
-18
-4% -$7.75K ﹤0.01% 1784
2021
Q3 		$216K Buy
+509
New +$215K ﹤0.01% 1750
2020
Q3 		– Sell
-177
Closed -$40K – 3036
2020
Q2 		$40K Buy
+177
New +$34.8K ﹤0.01% 2038

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Cetera Advisor Networks's WST Position: Q1 2024 in Review

Cetera Advisor Networks increased its West Pharmaceutical (WST) stake by 3.5% in Q1 2024, buying an estimated $183K and bringing the position to 14,673 shares worth $5.81M. The position accounts for 0.03% of the portfolio, ranked #566.

Cetera Advisor Networks first reported a position in WST in Q2 2020 and has held it in 10 quarters since. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Cetera Advisor Networks held 14,673 shares of West Pharmaceutical worth $5.81M as of Q1 2024.
  • Cetera Advisor Networks bought 495 West Pharmaceutical shares in Q1 2024, an estimated $183K.
  • West Pharmaceutical made up 0.03% of Cetera Advisor Networks's portfolio in Q1 2024, its #566 holding.
  • Cetera Advisor Networks first reported a position in West Pharmaceutical in Q2 2020 and has held it in 10 quarters since.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.